Insomnia Global Market Report 2025

Description

Insomnia is a sleep disorder characterized by difficulties in falling or staying asleep. Depending on the duration of symptoms, insomnia can be categorized as either short-term (acute) or long-term (chronic). Various treatments, including drugs, digital therapeutics, and devices, are employed to address insomnia conditions.

The main therapy types for insomnia encompass non-pharmacological therapy and pharmacological therapy. Non-pharmacological interventions (NPI) or non-pharmacological therapies involve non-chemical interventions performed on and benefiting the patient, such as light therapy and exercise. The various drug classes utilized in pharmacological therapy include anti-depressants, melatonin antagonists, benzodiazepines, non-benzodiazepines, orexin antagonists, and others. These drugs are administered through various routes, such as oral and parenteral, and are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The insomnia market research report is one of a series of new reports from The Business Research Company that provides insomnia market statistics, including insomnia industry global market size, regional shares, competitors with an insomnia market share, detailed insomnia market segments, market trends, and opportunities, and any further data you may need to thrive in the insomnia industry. This insomnia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insomnia market size has grown steadily in recent years. It will grow from $5 billion in 2024 to $5.24 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increased stress levels, prevalence of mental health conditions, shift work and irregular work hours, increased awareness and diagnosis, high consumption of stimulants

The insomnia market size is expected to see strong growth in the next few years. It will grow to $6.62 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to global health crisis impact, increasing awareness of sleep hygiene, emphasis on mental health and wellness, government initiatives for sleep health, influence of social determinants. Major trends in the forecast period include digital health solutions for sleep monitoring, cognitive behavioral therapy for insomnia, telehealth for sleep consultations, integration of sleep health into primary care, research on novel therapeutic targets.

The increase in work-related stress is expected to drive growth in the insomnia market in the future. Work-related stress refers to harmful emotional and physical responses that arise when the demands and pressures of work do not align with a worker's resources, capabilities, or knowledge. This type of job stress can lead to various health issues, including insomnia. Depending on the severity of the insomnia, patients may be treated with medications or cognitive-behavioral therapies, among other approaches. For example, in October 2022, the American Psychological Association, a U.S.-based organization of psychologists, reported that workplace stress remains a significant concern, with 77% of employees indicating they experienced work-related stress in the past month. Additionally, 57% reported negative effects, such as emotional exhaustion (31%), which are often associated with workplace burnout. Therefore, the surge in work-related stress is propelling the growth of the insomnia market.

The growth of the insomnia market is also expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, lasting for three months or more and worsening over time, often lead to comorbid conditions such as insomnia. Individuals with chronic conditions such as cardiovascular disorders, diabetes, and chronic pain frequently experience sleep-related issues. The rising prevalence of chronic diseases creates a demand for effective insomnia treatments and management strategies, contributing to the growth of the market. According to the National Center for Biotechnology Information in January 2023, the global number of people with chronic diseases is projected to reach 142.66 million by 2050, up from 71.522 million in 2020. Therefore, the increasing prevalence of chronic diseases is a significant factor driving the growth of the insomnia market.

A key trend in the insomnia market is the adoption of product innovation. Major companies in the insomnia therapeutics market are developing innovative treatments to maintain their market positions. For example, WELT, a Korea-based medical device company, received approval for its digital insomnia treatment device, WELT-I, in April 2023. WELT-I is designed to correct behavioral, psychological, and cognitive factors contributing to insomnia. It delivers treatment based on cognitive behavioral therapy (CBT), a first-line treatment for insomnia. The device, classified as software as a medical device (SaMD), analyzes sleep patterns, intervenes in patient behavior, and delivers personalized relaxation therapy for eight weeks to improve sleep quality and reduce tension and anxiety.

Major companies in the insomnia market are introducing new products, such as zaleplon-based insomnia drugs, to gain a competitive edge. Zaleplon, a non-benzodiazepine sedative-hypnotic medication, is used for the short-term treatment of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical company, launched Zaledeep Cap., the first insomnia treatment in South Korea utilizing zaleplon as its main ingredient. Zaleplon is known for its rapid onset of action, short half-life, and minimal impact on daily activities. The launch of Zaledeep Cap. aims to provide a new and effective treatment option for individuals suffering from insomnia in response to the increasing cases in modern society.

In August 2022, ResMed, a US-based medical equipment company, acquired Mementor to strengthen its sleep portfolio in Germany. This acquisition included somnio, a digital solution for insomnia, Germany's first and only permanently approved digital health application (DiGA) in sleep medicine. Somnio focuses on improving sleep in insomnia patients, addressing the care gap, and providing alternatives to prevailing drug therapy. Mementor, a Germany-based developer of digital insomnia therapy solutions, contributes to ResMed's overall commitment to enhancing sleep-related healthcare.

Major companies operating in the insomnia market include Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

North America was the largest region in the insomnia market in 2024. The regions covered in the insomnia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insomnia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insomnia market consists of revenues earned by entities by providing therapies such as light therapy, stimulus control therapy, and relaxation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The insomnia market also includes sales of triazolam, estazolam, temazepam, quazepam, and flurazepam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insomnia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insomnia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insomnia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insomnia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Non-Pharmacological Therapy; Pharmacological Therapy
2) By Drug Class: Anti-Depressants; Melatonin Antagonist; Benzodiazepines; Nonbenzodiazepines; Orexin Antagonist; Other Drug Classes
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I); Sleep Hygiene Education; Relaxation Techniques; Stimulus Control Therapy; Sleep Restriction Therapy
2) By Pharmacological Therapy: Prescription Medications; Over-The-Counter; Herbal Supplements
Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Sanofi S.A.; GlaxoSmithKline plc.; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25041

1. Executive Summary

2. Insomnia Market Characteristics

3. Insomnia Market Trends And Strategies

4. Insomnia Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Insomnia Growth Analysis And Strategic Analysis Framework

5.1. Global Insomnia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Insomnia Market Growth Rate Analysis
5.4. Global Insomnia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Insomnia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Insomnia Total Addressable Market (TAM)

6. Insomnia Market Segmentation

6.1. Global Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Pharmacological Therapy
Pharmacological Therapy
6.2. Global Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Depressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Other Drug Classes
6.3. Global Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Route Of Administration
6.4. Global Insomnia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Insomnia Market, Sub-Segmentation Of Non-Pharmacological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cognitive Behavioral Therapy For Insomnia (CBT-I)
Sleep Hygiene Education
Relaxation Techniques
Stimulus Control Therapy
Sleep Restriction Therapy
6.6. Global Insomnia Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Medications
Over-The-Counter
Herbal Supplements

7. Insomnia Market Regional And Country Analysis

7.1. Global Insomnia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Insomnia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Insomnia Market

8.1. Asia-Pacific Insomnia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Insomnia Market

9.1. China Insomnia Market Overview
9.2. China Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Insomnia Market

10.1. India Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Insomnia Market

11.1. Japan Insomnia Market Overview
11.2. Japan Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Insomnia Market

12.1. Australia Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Insomnia Market

13.1. Indonesia Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Insomnia Market

14.1. South Korea Insomnia Market Overview
14.2. South Korea Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Insomnia Market

15.1. Western Europe Insomnia Market Overview
15.2. Western Europe Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Insomnia Market

16.1. UK Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Insomnia Market

17.1. Germany Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Insomnia Market

18.1. France Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Insomnia Market

19.1. Italy Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Insomnia Market

20.1. Spain Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Insomnia Market

21.1. Eastern Europe Insomnia Market Overview
21.2. Eastern Europe Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Insomnia Market

22.1. Russia Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Insomnia Market

23.1. North America Insomnia Market Overview
23.2. North America Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Insomnia Market

24.1. USA Insomnia Market Overview
24.2. USA Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Insomnia Market

25.1. Canada Insomnia Market Overview
25.2. Canada Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Insomnia Market

26.1. South America Insomnia Market Overview
26.2. South America Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Insomnia Market

27.1. Brazil Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Insomnia Market

28.1. Middle East Insomnia Market Overview
28.2. Middle East Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Insomnia Market

29.1. Africa Insomnia Market Overview
29.2. Africa Insomnia Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Insomnia Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Insomnia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Insomnia Market Competitive Landscape And Company Profiles

30.1. Insomnia Market Competitive Landscape
30.2. Insomnia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Insomnia Market Other Major And Innovative Companies

31.1. Koninklijke Philips N.V.
31.2. Viatris Inc.
31.3. Astellas Pharma Inc.
31.4. Sun Pharmaceutical Industries Limited
31.5. Eisai Co.Ltd.
31.6. UCLA Health Insomnia Clinic
31.7. Jazz Pharmaceuticals PLC
31.8. Aurobindo Pharma Limited
31.9. Purdue Pharma LP
31.10. Cipla Inc.
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Zydus Lifesciences Limited
31.13. Lupin Limited
31.14. Mallinckrodt Pharmaceuticals Plc.
31.15. Fisher & Paykel Healthcare Corporation Limited

32. Global Insomnia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insomnia Market

34. Recent Developments In The Insomnia Market

35. Insomnia Market High Potential Countries, Segments and Strategies

35.1 Insomnia Market In 2029 - Countries Offering Most New Opportunities
35.2 Insomnia Market In 2029 - Segments Offering Most New Opportunities
35.3 Insomnia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer